Enzo Biochem Inc/ US2941001024 /
| 2024-04-16 10:10:00 PM | Chg. -0.01 | Volume | Bid2024-04-16 | Ask2024-04-16 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.15USD | -0.86% | 54,912 Turnover: 53,773.73 |
1.07Bid Size: 100 | 1.29Ask Size: 100 | 58.91 mill.USD | - | 2.80 |
Assets
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 7.9480 | 8.2140 | 7.9010 | 7.6360 | 14.2540 | ||||||
| Intangible Assets | 6.1550 | 4.4220 | 2.8950 | 1.8860 | 1.0320 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 21.9080 | 20.4240 | 18.5810 | 18.4600 | 25.1870 | ||||||
| Inventories | 7.3960 | 6.9710 | 7.0470 | 7.2780 | 7.8420 | ||||||
| Accounts Receivable | 12.1090 | 14.5920 | 15.1800 | 13.1470 | 10.7380 | ||||||
| Cash and Cash Equivalents | 18.1090 | 67.7770 | 64.1670 | 60.0410 | 60.1460 | ||||||
| Current Assets | 46.4860 | 91.3970 | 89.0840 | 83.2000 | 81.4530 | ||||||
| Total Assets | 68.3940 | 111.8210 | 107.6650 | 101.6600 | 106.6400 | ||||||
Liabilities
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 8.7620 | 9.8570 | 10.3500 | 9.5160 | 7.2560 | ||||||
| Long-term debt | - | - | - | - | 4.1790 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 11.3400 | 8.2000 | 6.7000 | 10.1000 | 8.4000 | ||||||
| Liabilities | 25.7880 | 22.2670 | 18.7930 | 20.5390 | 20.6120 | ||||||
| Share Capital | .4610 | .4630 | - | .4720 | .4760 | ||||||
| Total Equity | 42.6060 | 89.5540 | 88.8720 | 81.1210 | 86.0280 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 68.3940 | 111.8210 | 107.6650 | 101.6600 | 106.6400 | ||||||
Income Statement
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 97.5990 | 102.7730 | 107.8040 | 104.7130 | 81.1700 | ||||||
| Depreciation (total) | 3.7890 | 3.8400 | 3.5980 | 3.1300 | 3.0360 | ||||||
| Operating Result | -1.2060 | 47.0030 | -3.0660 | -12.1640 | 1.7330 | ||||||
| Interest Income | -.2450 | -.1360 | .3840 | .8530 | 1.0560 | ||||||
| Income Before Taxes | -2.2920 | 46.5150 | -2.4220 | -11.4180 | 2.4890 | ||||||
| Income Taxes | -.0070 | 1.2290 | .0820 | -1.0970 | 0.0000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -2.2850 | 45.2860 | -2.5040 | -10.3210 | 2.4890 | ||||||
Per Share
Cash Flow
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -3.7000 | 53.1260 | -.2050 | -2.7350 | 4.8060 | ||||||
| Cash Flow from Investing Activities | -1.7520 | -1.5120 | -1.7490 | -1.9440 | -8.1260 | ||||||
| Cash Flow from Financing | 6.2250 | -1.9310 | -1.6690 | .5590 | 4.1930 | ||||||
| Decrease / Increase in Cash | .6540 | 49.6680 | -3.6100 | -4.1260 | .8550 | ||||||
| Employees | 483 | 489 | 472 | 460 | 500 | ||||||
